SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:gup.ub.gu.se/292801"
 

Sökning: onr:"swepub:oai:gup.ub.gu.se/292801" > Potentiation of the...

Potentiation of the antihypertensive effect of enalapril by randomized addition of different doses of hydrochlorothiazide.

Dahlöf, Björn, 1953 (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
Andrén, Lennart, 1946 (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
Eggertsen, Robert, 1948 (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
visa fler...
Jern, Sverker, 1954 (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
SVensson, Anders (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
Hansson, Lennart (författare)
Gothenburg University,Göteborgs universitet,Medicinska institutionen,Department medicine
visa färre...
 (creator_code:org_t)
1985
1985
Engelska.
Ingår i: Journal of hypertension. Supplement : official journal of the International Society of Hypertension. - 0952-1178. ; 3:3, s. S483-6
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • The purpose of this study was to evaluate the potentiating effect of hydrochlorothiazide (HCTZ) 12.5 or 25 mg once daily when added in a placebo-controlled double-blind randomized study of patients with essential hypertension, whose diastolic blood pressure (DBP) was not adequately controlled (DBP > 90 mmHg) following 6 weeks of single-blind treatment with the angiotensin converting enzyme (ACE) inhibitor enalapril, 20 mg once daily. Forty-eight patients started the first period with enalapril after 4 weeks on placebo. In 13 patients DBP fell to < or = 90 mmHg after enalapril for 6 weeks. In this group supine mean arterial pressure (MAP) was reduced by 13% (P < 0.01). In the patients whose DBP was > 90 mmHg after 6 weeks on enalapril (n = 32) the average supine MAP fell by 9% (P < 0.001). After 3 weeks there was no further drop in blood pressure (BP). Addition of HCTZ to the 32 patients with DBP > 90 mmHg caused a significant further drop in supine BP by 13/7 mmHg with 12.5 mg and by 15/7 mmHg with 25 mg. Seven patients discontinued the study, none due to side effects on enalapril alone. Well-being, assessed with a special questionnaire, was significantly better with enalapril as monotherapy compared with previous treatment, but not different from well-being during the placebo periods. It is concluded that 20 mg enalapril once daily lowered BP effectively and was well tolerated. The maximum BP lowering effect was seen within 3 weeks. Addition of HCTZ caused a significant, and clinically relevant, further drop in BP.(ABSTRACT TRUNCATED AT 250 WORDS)

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Allmänmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- General Practice (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Nyckelord

Adult
Double-Blind Method
Drug Synergism
Drug Therapy
Combination
Enalapril
administration & dosage
adverse effects
therapeutic use
Female
Humans
Hydrochlorothiazide
administration & dosage
adverse effects
therapeutic use
Hypertension
drug therapy
physiopathology
psychology
Male
Middle Aged
Single-Blind Method

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy